Multimodality MRI and Liquid Biopsy in Gliblastoma

Site Image

Study Overview

We are seeking to enroll up to 30 subjects with newly diagnosed or recurrent GBM who will undergo a clinical brain MRI examination with and without contrast prior to surgery. Participants will also have a blood draw pre-operatively to collect samples for cfDNA and ctDNA analysis. MRI imaging will include an injection of intravenous infusion of 5 mg/kg ferumoxytol in addition to routine pre and post-contrast sequences after gadolinium injection. Subsequently, three different sites in the enhancing component of the tumor of each participant will be selected for intraoperative sampling based on hypointense signal on multi-echo gradient-recalled echo sequence that reflect ferumoxytol-induced signal drop.

  • Study Identifier: 843601

Recruitment Status

Open

Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Sign-up

Participate in medical studies to develop new diagnostic and clinical treatments and improve current standards of care.

Sign Up Now!

If you need assistance finding a non-cancer study or if you have any questions, please email psom-ocr@pobox.upenn.edu